Study title and authors:
The influence of atorvastatin on walking performance in peripheral arterial disease.
Bregar U, Poredos P, Sabovic M, Jug B, Sebestjen M.
Department of Vascular Disease, University of Ljubljana Medical Centre, Ljubljana, Slovenia.
This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/19588303
The study also measured the Ankle Brachial Pressure Index. The Ankle Brachial Pressure Index (ABPI), known more commonly as an ABI, is the ratio of the blood pressure in the lower legs to the blood pressure in the arms. Compared to the arm, lower blood pressure in the leg is an indication of blocked arteries (peripheral vascular disease). The ABI is calculated by dividing the systolic blood pressure at the ankle by the systolic blood pressures in the arm.
The study found:
(a) The ankle-brachial pressure index (ABPI) did not change significantly in either group.
(b) After 3 months the pain-free walking distance increased 41% in the statin group.
(c) After 3 months the pain-free walking distance increased 100% in the placebo group.
(i) Statins did not improve peripheral arterial disease (no change in the ankle-brachial pressure index).
(ii) The placebo group increased their pain-free walking distance by an extra 59% compared to the statin users. It may be argued that statins inhibited the expected progress of pain-free walking distance that 3 months of regular exercise shoud induce.
More information on this subject: Books : Scientific Studies : Other Websites : Videos : Food Mall